Back to Trades
Hansen Gwenn
Chief Scientific OfficerCIK 0001817160
Total Volume
$2.4M
13 filings
Purchases
$0
0 buy txns
Sales
$780.6K
12 sell txns
Net Activity
-$780.6K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 13
- Buy transactions
- 0
- Sell transactions
- 12
- Companies
- 1
- Active
- 2025–2026
Hansen Gwenn, Chief Scientific Officer, accounts for 13 disclosed filings worth $2.4M, all concentrated in Nurix Therapeutics, Inc. (NRIX), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $780.6K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
13 loaded
| Nov 2 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $142.9K |
| Oct 15 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $36.3K |
| Sep 1 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $37.0K |
| Aug 5 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $108.9K |
| Aug 5 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $100.1K |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $90.0K |
| Jun 25 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $107.9K |
| Apr 30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $53.5K |
| Feb 10 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Award | $1.5M |
| Feb 3 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Exercise | $52.6K |
| Oct 30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $52.3K |
| Oct 23 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Award | $0 |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $51.7K |
13 filings